A year has 8,760 hours. Support the campaign
Vitruvian Shield
Neurology

Neurology and epilepsy research

Continuous EEG via reusable dry-electrode systems, structured seizure event logging with investigator review, and neurology-specific patient diaries for decentralised trials.

Advancing neurological research with continuous monitoring

Neurological conditions are inherently episodic and unpredictable. Seizures, sleep disturbances, and movement fluctuations cannot be reliably captured during scheduled clinic visits. Vitruvian Shield enables continuous, real-world neurological data collection through reusable dry-electrode EEG systems and structured investigator-review workflows purpose-built for decentralised and hybrid trials.

Our platform is being prepared for the PT-EPI-DCT-002 study, a single-site decentralised epilepsy study with ULS Santa Maria, Lisbon, collecting multi-modal data, including electrodermal activity (EDA), accelerometry, and heart rate variability (HRV), to support structured seizure event logging and investigator review. Automated algorithmic seizure classification is on our regulatory roadmap and is not claimed as a current feature. ULS Santa Maria is a partner under a non-binding letter of intent.

Neurology-specific capabilities

Structured seizure event logging

Investigator-review workflows for seizure events reported by patients or flagged by multi-modal sensor data (EDA, accelerometry, HRV). Every event is adjudicated by the clinical team before being counted, supporting rigorous endpoint capture in decentralised epilepsy research.

Continuous EEG integration

Integration with reusable dry-electrode EEG systems designed for ambulatory and home-use studies, with long-term recording and cross-referencing between patient diaries and EEG data during investigator review.

Digital biomarker collection

Passive collection of activity patterns through smartphone sensors and wearables. Gait metrics and tremor quantification as neurological digital biomarkers are in development.

Sleep architecture and circadian patterns (in development)

In development: sleep staging and circadian pattern analysis from EEG and accelerometry data, for longitudinal sleep quality tracking in neurological research where sleep disruption is both a symptom and a therapeutic target.

Electronic seizure diaries

Patient-friendly seizure diary with customisable seizure-type classification, trigger logging, medication tracking and prompts for timely reporting, built for epilepsy and other neurological decentralised trials.

Study spotlight: PT-EPI-DCT-002

Our decentralised epilepsy study, in preparation with ULS Santa Maria, will collect multi-modal data (EDA, accelerometry, HRV) alongside EEG and patient diaries to support structured investigator review. The data also informs our regulatory roadmap toward future algorithmic seizure classification capabilities. ULS Santa Maria is a partner under a non-binding letter of intent.

Study in preparation

PT-EPI-DCT-002, decentralised seizure monitoring in adult epilepsy, ULS Santa Maria.

PT-EPI-DCT-002

Decentralised seizure monitoring in adult epilepsy

In preparation

Single-site decentralised study, version 2.0, with ULS Santa Maria, Lisbon. Devices: wrist-worn research wearable (primary), dry-electrode EEG headband, camera-based vital signs during video visits. Ethics submission targeted before the end of 2026. Participant numbers and the principal investigator are published on authorisation. ULS Santa Maria is a partner under a non-binding letter of intent.

Study identifier
PT-EPI-DCT-002
Instruments and devices
Wrist-worn research wearable (primary), dry-electrode EEG headband, camera-based vital signs during video visits
Clinical setting
ULS Santa Maria, Lisbon, under the TB4Health non-binding letter of intent of 28 June 2026.
Timeline
Ethics submission targeted before the end of 2026.

Participant numbers and the principal investigator are published on authorisation. No study result is claimed.

Talk to us about your next study

Tell us about the protocol, the countries and the devices. We will show you how the platform would run it.